IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $331,672 | +12.7% | 7,312 | +2.0% | 0.03% | +14.8% |
Q2 2023 | $294,226 | -38.3% | 7,171 | -43.2% | 0.03% | -70.3% |
Q4 2022 | $476,808 | +5.3% | 12,624 | +23.2% | 0.09% | -3.2% |
Q3 2022 | $453,000 | 0.0% | 10,248 | -16.2% | 0.09% | -45.7% |
Q2 2022 | $453,000 | +62.9% | 12,225 | +62.6% | 0.17% | +66.3% |
Q1 2022 | $278,000 | -22.8% | 7,518 | -36.5% | 0.10% | +8.3% |
Q4 2021 | $360,000 | +6.2% | 11,845 | +106.0% | 0.10% | +28.0% |
Q2 2020 | $339,000 | 0.0% | 5,749 | -19.8% | 0.08% | -93.1% |
Q1 2020 | $339,000 | – | 7,168 | – | 1.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |